explore -WSS

explore

author：fashion 2025-09-29 02:18:31 - browse：3245

Balance innovation — A federal judge made a key ruling in a lawsuit challenging a new drug pricing program Adobe

WASHINGTON — A federal court judge allowed a new Medicare drug price negotiation program to proceed while the court deliberates whether it is constitutional.

The case centers on Democrats’ new law, which empowered the Medicare program to start negotiating lower prices for certain medicines that are especially expensive for the government. Judge Michael Newman, a Trump appointee to the U.S. District Court for the Southern District of Ohio, ruled against the U.S. Chamber of Commerce, which had sued the federal government and asked for the program to be stopped while litigation continues.

Medicare officials announced the first 10 drugs they would negotiate over last month, and the deadline for the pharmaceutical companies to sign agreements to start bargaining is Oct. 1. The Chamber of Commerce had requested a decision on the preliminary injunction by that date.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Melinda French Gates resigns from Gates Foundation

WSS

Questions and answers about ramping up H5N1 bird flu vaccine

Bird flu surveillance in wastewater gets boost from consortium

FTC falls short on scrutinizing hospital mergers, study says

H5N1 bird flu outbreak: Second human case reported, in Michigan

FTC falls short on scrutinizing hospital mergers, study says

Eyeing GLP

explore

explore

Wikipedia

Affirmative action in medical school literally saved lives

Bird flu outbreak in cows is latest avian flu curveball

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Medical leaders decry Supreme Court decision on affirmative action

ASCO eve: Let’s set the table for this year's meeting

Moonlake's readout produced a cash windfall. Risks remain

UnitedHealth financials solid despite Change Healthcare cyberattack

Hollywood unions extend contract negotiations for actors

FDA poised to publish guidelines for clinical trial diversity

entertainment

Bird flu surveillance in wastewater gets boost from consortium

Reports of telehealth's death have been greatly exaggerated

Key Senate committee drafts bipartisan bill to stem drug shortages

MultiPlan and major insurers sued for alleged medical price

For longer

Getting Alzheimer's drug Leqembi to patients can be a challenge

leisure time

hotspot

hotspot

entertainment